Stay updated on MDMA in Moderate Hepatic Impairment Clinical Trial

Sign up to get notified when there's something new on the MDMA in Moderate Hepatic Impairment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MDMA in Moderate Hepatic Impairment Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The study record history now shows the latest revision as v3.6.3, replacing v3.6.2. This reflects a new version added to the page's history.
    Difference
    0.1%
    Check dated 2026-07-04T13:09:53.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A new revision entry, Revision: v3.6.2, was added to the history and the older Revision: v3.6.0 entry was removed. This updates the page to reflect the latest revision in the record history.
    Difference
    0.1%
    Check dated 2026-06-27T07:38:13.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The study record history now includes options to check who can join and to find contact information. A new page revision note shows 'Revision: v3.6.0', indicating an update to the site's version.
    Difference
    0.4%
    Check dated 2026-06-13T01:28:07.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page history now shows a new revision, v3.5.5, replacing the previous v3.5.4, indicating an administrative update to the record metadata rather than substantive trial content.
    Difference
    0.1%
    Check dated 2026-06-05T22:01:19.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The Record History now shows a new revision label (v3.5.4) replacing the previous v3.5.3, indicating an update to the page's revision metadata rather than changes to the study data or descriptions.
    Difference
    0.1%
    Check dated 2026-05-15T14:58:07.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Resilient Pharmaceuticals is now listed as the Sponsor/Responsible Party, replacing Lykos Therapeutics, indicating a shift in the organization accountable for the study records. This change affects who coordinates communications and regulatory submissions for the trial.
    Difference
    0.2%
    Check dated 2026-05-01T09:19:30.000Z thumbnail image

Stay in the know with updates to MDMA in Moderate Hepatic Impairment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MDMA in Moderate Hepatic Impairment Clinical Trial page.